{Reference Type}: Journal Article
{Title}: A conjugate vaccine strategy that induces protective immunity against arecoline.
{Author}: Yin XG;Chen XZ;Qiu JL;Yu ZK;Chen LY;Huang SQ;Huang WN;Luo X;Zhu KW;
{Journal}: Eur J Med Chem
{Volume}: 268
{Issue}: 0
{Year}: 2024 Mar 15
{Factor}: 7.088
{DOI}: 10.1016/j.ejmech.2024.116229
{Abstract}: Betel-quid chewing addiction is the leading cause of oral submucous fibrosis and oral cancer, resulting in significant socio-economic burdens. Vaccination may serve as a promising potential remedy to mitigate the abuse and combat accidental overdose of betel nut. Hapten design is the crucial factor to the development of arecoline vaccine that determines the efficacy of a candidate vaccine. Herein, we reported that two kinds of novel arecoline-based haptens were synthesized and conjugated to Bovine Serum Albumin (BSA) to generate immunogens, which generated antibodies with high affinity for arecoline but reduced binding for guvacoline and no affinity for arecaidine or guvacine. Notably, vaccination with Arec-N-BSA, which via the N-position on the tetrahydropyridine ring (tertiary amine group), led to a higher antibody affinity compared to Arec-CONH-BSA, blunted analgesia and attenuated hypothermia for arecoline.